APA (7th ed.) Citation

Popovic, D. S., Papanas, N., Koufakis, T., Kotsa, K., Mahmeed, W. A., Al-Rasadi, K., . . . Lessan, N. (2023). Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel. Experimental & Clinical Endocrinology & Diabetes, 131(5), 260. https://doi.org/10.1055/a-2019-1111

Chicago Style (17th ed.) Citation

Popovic, Djordje S., et al. "Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel." Experimental & Clinical Endocrinology & Diabetes 131, no. 5 (2023): 260. https://doi.org/10.1055/a-2019-1111.

MLA (9th ed.) Citation

Popovic, Djordje S., et al. "Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel." Experimental & Clinical Endocrinology & Diabetes, vol. 131, no. 5, 2023, p. 260, https://doi.org/10.1055/a-2019-1111.